Vanda Pharmaceuticals Inc. recently made a significant move by filing a new drug application for Tradipitant. The application, targeted at addressing motion sickness, was publicized through a social ...
GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and ...
Key secondary end points included duration of response, overall survival, pharmacokinetics, quality of life, safety, and tolerability. 1. New Drug Application initiated with U.S. FDA for TAR-200, the ...
Let me emphasize that the exemption granted to PNP personnel only applies exclusively for their application for a new or renewal of license to own and possess firearms,' says DILG Secretary Jonvic Rem ...
has accepted for review the New Drug Application (NDA) for its novel Bumetanide Nasal Spray (RSQ-777). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ...